miR-663 was shown to be elevated in nasopharyngeal cancer, and it functions as an oncogene by directly targeting p21CIP1 to promote the cellular G1/S transition both in vitro and in vivo. Here, CDKN1A is linked to nasopharyngeal carcinoma.